1372514 - Eyegate Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - EYEG (1372514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
32 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+13+7+15+64
S2-4-4-14+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

AM
2018-06-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.53+18,815309,912+6%+$9,924
M
2018-06-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.54+9,215300,312+3%+$4,932
M
2018-05-25
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.57+58,27533,605,0000%+$33,433
2018-05-18
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.56+1,72533,488,4500%+$959
2018-05-14
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.53+15,75833,485,0000%+$8,417
M
2018-05-09
EYEGArmistice Capital, LLC10%P - Purchase$0.51+177,01233,453,484+1%+$90,992
M
2018-05-04
EYEGArmistice Capital, LLC10%P - Purchase$0.46+137,23033,099,4600%+$63,472
M
2018-04-25
EYEGArmistice Capital, LLC10%P - Purchase$0.54+165,52232,825,000+1%+$89,266
M
2018-04-18
EYEGArmistice Capital, LLC10%P - Purchase$0.49+2,534,47832,493,956+8%+$1,231,159
D
2018-04-17
EYEGGaranzini MichaelChief Commercial OfficerP - Purchase$0.00+156,250171,250>999%+$0
D
2018-04-17
EYEGFrom StephenPres, CEOP - Purchase$0.00+125,000409,820+44%+$0
D
2018-04-17
EYEGRomano SarahCFOP - Purchase$0.00+62,500106,863+141%+$0
DM
2018-04-13
EYEGArmistice Capital, LLC10%P - Purchase$0.36+10,479,97027,425,000+62%+$3,740,050
2017-11-17
EYEGGaranzini MichaelChief Commercial OfficerA - Grant$1.07+15,00015,000New+$16,050
M
2017-09-14
EYEGWirostko BarbaraChief Medical OfficerA - Grant$1.22+19,200278,742+7%+$23,334
2017-08-15
EYEGRomano SarahInterim CFOP - Purchase$1.00+10,00032,500+44%+$10,000
2017-08-10
EYEGFrom StephenPres, CEOP - Purchase$1.03+12,500272,465+5%+$12,875
D
2017-06-14
EYEGRomano SarahInterim CFOP - Purchase$0.00+20,00022,500+800%+$0
D
2017-06-14
EYEGFrom StephenPres, CEOP - Purchase$0.00+60,000259,965+30%+$0
D
2017-06-02
EYEGChaney Paul GDirM - OptEx$0.65+17,57041,229+74%+$11,421
D
2017-05-15
EYEGManzo Michael P.VP of EngineeringM - OptEx$0.65+7,28519,546+59%+$4,735
2017-03-13
EYEGVentech Capital II10%S - Sale$2.80-4,4191,431,8140%-$12,385-4-1-13
2017-03-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$2.83+8,700259,542+3%+$24,621-7-3-12
2017-03-06
EYEGGoldberg MortonDirS - Sale$3.00-8,9199,441-49%-$26,757-4-8-15
2017-02-28
EYEGWirostko BarbaraChief Medical OfficerA - Grant$2.59+95,900250,842+62%+$248,798-4+1-11
D
2017-02-27
EYEGGoldberg MortonDirM - OptEx$1.70+1,08318,360+6%+$1,841-4+1-11
2017-02-06
EYEGRomano SarahInterim CFOA - Grant$0.00+2,5002,500New+$0+4+4+61
2017-02-06
EYEGMann BrendaVP of Research, DevelopmentA - Grant$0.00+2,50011,751+27%+$0+1+5+66
2017-02-06
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.00+15,000154,942+11%+$0+1+5+66
2017-02-06
EYEGFrom StephenPres, CEOA - Grant$0.00+60,000199,965+43%+$0+1+5+66
2016-09-15
EYEGFrom StephenPres, CEOP - Purchase$1.49+15,000139,965+12%+$22,338+13+7+15+64
D
2016-06-30
EYEGFrom StephenPres, CEOM - OptEx$0.65+52,990124,965+74%+$34,327-5-4-20-37

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top